PEDIATRICS Vol. 114 No. 3 September 2004, pp. 584-591 (doi:10.1542/10.1542/peds.2003-1177-L)
Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association



* Statistics Unit
Immunisation Department, Health Protection Agency, Communicable Disease Surveillance Centre, London, United Kingdom
Centre for Community Child Health, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom
|| Morbidity and Health Care Team, Office for National Statistics, London, United Kingdom
Objective. After concerns about the possible toxicity of thimerosal-containing vaccines in the United States, this study was designed to investigate whether there is a relationship between the amount of thimerosal that an infant receives via diphtheria-tetanus-whole-cell pertussis (DTP) or diphtheria-tetanus (DT) vaccination at a young age and subsequent neurodevelopmental disorders.
Methods. A retrospective cohort study was performed using 109 863 children who were born from 1988 to 1997 and were registered in general practices in the United Kingdom that contributed to a research database. The disorders investigated were general developmental disorders, language or speech delay, tics, attention-deficit disorder, autism, unspecified developmental delays, behavior problems, encopresis, and enuresis. Exposure was defined according to the number of DTP/DT doses received by 3 and 4 months of age and also the cumulative age-specific DTP/DT exposure by 6 months. Each DTP/DT dose of vaccine contains 50 µg of thimerosal (25 µg of ethyl mercury). Hazard ratios (HRs) for the disorders were calculated per dose of DTP/DT vaccine or per unit of cumulative DTP/DT exposure.
Results. Only in 1 analysis for tics was there some evidence of a higher risk with increasing doses (Cox's HR: 1.50 per dose at 4 months; 95% confidence interval [CI]: 1.022.20). Statistically significant negative associations with increasing doses at 4 months were found for general developmental disorders (HR: 0.87; 95% CI: 0.810.93), unspecified developmental delay (HR: 0.80; 95% CI: 0.690.92), and attention-deficit disorder (HR: 0.79; 95% CI: 0.640.98). For the other disorders, there was no evidence of an association with thimerosal exposure.
Conclusions. With the possible exception of tics, there was no evidence that thimerosal exposure via DTP/DT vaccines causes neurodevelopmental disorders.
Key Words: cohort study neurodevelopment safety thimerosal thiomersal vaccines
Abbreviations: Hg, mercury WHO, World Health Organization VSD, Vaccine Safety Datalink CDC, Centers for Disease Control and Prevention HMO, health maintenance organization ADD, attention-deficit disorder GPRD, General Practice Research Database ICD, International Classification of Diseases DTP, diphtheria-tetanus-whole-cell pertussis DT, diphtheria, tetanus GP, general practitioner HR, hazard ratio CI, confidence interval
Accepted Mar 15, 2004.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. E. Tozzi, P. Bisiacchi, V. Tarantino, B. De Mei, L. D'Elia, F. Chiarotti, and S. Salmaso Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines Pediatrics, February 1, 2009; 123(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. West, S. C. Marcus, J. Wilk, L. M. Countis, D. A. Regier, and M. Olfson Use of Depot Antipsychotic Medications for Medication Nonadherence in Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schechter and J. K. Grether Continuing Increases in Autism Reported to California's Developmental Services System: Mercury in Retrograde Arch Gen Psychiatry, January 1, 2008; 65(1): 19 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Thompson, C. Price, B. Goodson, D. K. Shay, P. Benson, V. L. Hinrichsen, E. Lewis, E. Eriksen, P. Ray, S. M. Marcy, et al. Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years N. Engl. J. Med., September 27, 2007; 357(13): 1281 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Woo, R. Ball, R. Landa, A. W. Zimmerman, M. M. Braun, and VAERS Working Group, Center for Biologics Evaluati Developmental regression and autism reported to the Vaccine Adverse Event Reporting System Autism, July 1, 2007; 11(4): 301 - 310. [Abstract] [PDF] |
||||
![]() |
A Swidsinski, O Goktas, C Bessler, V Loening-Baucke, L P Hale, H Andree, M Weizenegger, M Holzl, H Scherer, and H Lochs Spatial organisation of microbiota in quiescent adenoiditis and tonsillitis J. Clin. Pathol., March 1, 2007; 60(3): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fombonne, R. Zakarian, A. Bennett, L. Meng, and D. McLean-Heywood Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations Pediatrics, July 1, 2006; 118(1): e139 - e150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Stern and H. Markel The History Of Vaccines And Immunization: Familiar Patterns, New Challenges Health Aff., May 1, 2005; 24(3): 611 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Offit Why Are Pharmaceutical Companies Gradually Abandoning Vaccines? Health Aff., May 1, 2005; 24(3): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Nolen U.K. studies refute thimerosal-autism link AAP News, September 1, 2004; 25(3): 105 - 114. [Full Text] [PDF] |
||||
![]() |
J. Heron, J. Golding, and and the ALSPAC Study Team Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association Pediatrics, September 1, 2004; 114(3): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Parker, B. Schwartz, J. Todd, and L. K. Pickering Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data Pediatrics, September 1, 2004; 114(3): 793 - 804. [Abstract] [Full Text] [PDF] |
||||
eLetters:
Read all eLetters
- THIMEROSAL DOES NOT BELONG IN VACCINES
- Mark R. Geier,MD, Ph.D., et al.
- Pediatrics Online, 8 Sep 2004 [Full text]
- Re: THIMEROSAL DOES NOT BELONG IN VACCINES
- Elizabeth Miller, et al.
- Pediatrics Online, 10 Sep 2004 [Full text]
- Does weight confound?
- John P. Heptonstall
- Pediatrics Online, 30 Oct 2004 [Full text]
- Re: Does weight confound?
- Nick J Andrews, et al.
- Pediatrics Online, 10 Nov 2004 [Full text]
- Re: Re: Does weight confound?
- John P Heptonstall
- Pediatrics Online, 24 Nov 2004 [Full text]
- Puzzling Circumstances
- John Stone
- Pediatrics Online, 1 May 2005 [Full text]
- Please can we have correct information about dosage?
- John Stone
- Pediatrics Online, 12 Jun 2005 [Full text]
- Re: Please can we have correct information about dosage?
- Elizabeth Miller, et al.
- Pediatrics Online, 5 Sep 2005 [Full text]
- Re: Re: Please can we have correct information about dosage?
- John Stone
- Pediatrics Online, 14 Sep 2005 [Full text]












